Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Iproceedings

Date Submitted: Jul 31, 2022
Date Accepted: Feb 28, 2023

The final, peer-reviewed published version of this preprint can be found here:

Out of Adversity Comes Opportunity: Smart-Colpo National Program for the Elimination of Carcinoma Cervix in a Post–COVID-19 World

R A, Gowda NR, H V, Prabhu M, Sharma JB, Vakharia K, Kumar A, M A V, Gatta S, Sareddy M, K P S, T K D, Desai D, Gopinath B, Viswanath S, Kini A

Out of Adversity Comes Opportunity: Smart-Colpo National Program for the Elimination of Carcinoma Cervix in a Post–COVID-19 World

Iproc 2023;9:e41571

DOI: 10.2196/41571

“Out of adversity comes opportunity: Smart-Colpo national program for elimination of carcinoma cervix in post COVID-19 world”

  • Anjali R; 
  • Naveen R Gowda; 
  • Vikas H; 
  • Meghana Prabhu; 
  • Jai Bhagwan Sharma; 
  • Khyati Vakharia; 
  • Atul Kumar; 
  • Akhila M V; 
  • Shilpa Gatta; 
  • Madhuri Sareddy; 
  • Sowmya K P; 
  • Divya T K; 
  • Devashish Desai; 
  • Bharath Gopinath; 
  • Somanath Viswanath; 
  • Ananth Kini

ABSTRACT

Background:

Carcinoma cervix is one of the leading causes of death among females worldwide. WHO has put forth the 90-70-90 global strategy for elimination of cervical cancer as a public health problem. It calls for 70% women to be screened at least once in their lifetime. This is as low as 1.9% for India and even lower for many other countries, making the target insurmountable especially in resource-constrained settings. COVID-19 pandemic made this further challenging.

Objective:

To identify bottlenecks, high leverage points and propose a technology driven national level program for improving screening of carcinoma cervix.

Methods:

Detailed process mapping was done to identify potential bottlenecks. Counterfactual approach to identify high leverage points for impact using “What if” scenarios was done. These findings were used to build program theory based logic models to propose a national level program for carcinoma cervix prevention.

Results:

Availability, accessibility, affordability, skewed distribution of infrastructure, cost implications and limited specialist manpower were identified as bottlenecks. COVID-19 pandemic put a strain on existing resources and worsened the situation. Existing network of primary healthcare workers, changes in health seeking behavior due to COVID-19 with increasing role of tele-health, conducive political milieu with initiatives like Digital India Mission and booming startup ecosystem were identified as high leverage points through counter-factual approach. Using these findings a national program was designed with program theory based logic modeling.

Conclusions:

The journey from <2% of women screened at least once in their lifetime all the way to 70% would need a drastic increase in funding and resource allocation which is unlikely considering the current conditions. COVID-19 has not only been an adversity but also opened new thinking & opportunities. Artificial Intelligence driven, cost-effective, easy to use and widely acceptable solutions like “Smart-Colpo” can be a game-changer to achieve the WHO targets.


 Citation

Please cite as:

R A, Gowda NR, H V, Prabhu M, Sharma JB, Vakharia K, Kumar A, M A V, Gatta S, Sareddy M, K P S, T K D, Desai D, Gopinath B, Viswanath S, Kini A

Out of Adversity Comes Opportunity: Smart-Colpo National Program for the Elimination of Carcinoma Cervix in a Post–COVID-19 World

Iproc 2023;9:e41571

DOI: 10.2196/41571

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.